MeSH tree: D03.383.725.547
A research team from the School of Clinical Medicine of the LKS Faculty of Medicine of the University of Hong Kong (HKUMed) has pioneered the use of a 'dual immunotherapy' combination—nivolumab and ipilimumab (NIVO+IPI)—in ...
Jun 16, 2025
0
44
Approximately 30% of the global population is affected by metabolic-associated fatty liver disease (MASLD), a condition that previously lacked targeted treatments. Researchers have now identified a genetic factor that exacerbates ...
May 16, 2025
0
247
Oral submucous fibrosis (OSF) is a serious disease that impairs mouth functionality, often leading to restricted opening and a high risk of malignant transformation. New research has uncovered a crucial player in this disease: ...
Apr 29, 2025
0
15
The U.S. Food and Drug Administration has approved Opdivo (nivolumab) plus Yervoy (ipilimumab) as a first-line treatment for adults with unresectable or metastatic hepatocellular carcinoma (HCC). The approval of Opdivo plus ...
Apr 16, 2025
0
17
If you head to the shops to buy bread, you'll face a variety of different options.
Mar 5, 2025
0
19
Chemotherapeutic agents are often used to treat cancer. They combat tumor growth, but also have a number of undesirable side effects. One of these is severe muscle wasting, known as chemotherapy-induced cachexia. This chronic ...
Jan 23, 2025
0
38
Recent results from the Phase III NRG-RTOG 1112 clinical study showed that the addition of stereotactic body radiotherapy (SBRT) to systemic therapy with sorafenib significantly improved progression-free survival (PFS) and ...
Dec 19, 2024
0
20
Psilocybin-assisted psychotherapy resulted in significant reductions in depression among clinicians who provided front-line COVID-19 care in 2020 and 2021. These reductions were measurably greater than those experienced by ...
Dec 5, 2024
0
48
In what appears to be an effort to bypass public health regulations covering vaping products, some tobacco companies have begun replacing nicotine in e-cigarettes with related chemicals that have similar properties but unknown ...
Aug 7, 2024
0
102
Over 700,000 people in the UK have glaucoma and it is the leading cause of irreversible blindness worldwide. The condition occurs when the cells in the eye that help you see (called retinal ganglion cells) start to die.
Jul 12, 2024
0
77
